tiprankstipranks

Gerald Ostrov Insider Profile

4 Followers
Gerald Ostrov, Director at Oramed Pharm, holds 38.90K shares in Entera Bio (Ticker: ENTX), holds 24.90K shares in Oramed Pharm (Ticker: ORMP), holds 39.35K shares in Orasure Technologies (Ticker: OSUR).
tipranks
Gerald Ostrov

Gerald Ostrov
Oramed Pharm (ORMP)
Director

Not Ranked
Gerald Ostrov has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$284K
50.45%
28.77%
20.78%
A breakdown of Gerald Ostrov's holdings

Insider Roles

Orasure Technologies
(OSUR)
Director
Entera Bio
(ENTX)
Director
Oramed Pharm
(ORMP)
Director
Roles that Gerald Ostrov holds in companies

Most Profitable Insider Trade

Stock:
Entera Bio
(ENTX)
Rating:Informative Buy
Date:Jan 25, 2022 - Jan 25, 2023
Return:-58.30%
The most profitable trade made by Gerald Ostrov

Gerald Ostrov's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Oramed Pharm
Feb 25, 2015
Director
Uninformative Buy
$59.00K
Entera Bio
Oct 04, 2024
Director
Uninformative Buy
$81.69K
Orasure Technologies
May 22, 2014
Director
Uninformative Buy
$143.22K
List of latest transactions for each holding click on a transaction to see Gerald Ostrov's performance on stock

Gerald Ostrov insider profile FAQ

What is the percentage of profitable transactions made by Gerald Ostrov?
The percentage of profitable transactions made by Gerald Ostrov is ―.
    What is the average return per transaction made by Gerald Ostrov?
    The average return per transaction made by Gerald Ostrov is ―.
      What stocks does Gerald Ostrov hold?
      Gerald Ostrov holds: ORMP, ENTX, OSUR stocks.
        What was Gerald Ostrov’s latest transaction?
        Gerald Ostrov latest transaction was an Uninformative Buy of ―.
          What was Gerald Ostrov's most profitable transaction?
          Gerald Ostrov’s most profitable transaction was an Informative Buy of ENTX stock on January 25, 2022. The return on the trade was -58.30%.
            What is Gerald Ostrov's role in Oramed Pharm?
            Gerald Ostrov's role in Oramed Pharm is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.